110
Participants
Start Date
July 1, 2014
Primary Completion Date
July 1, 2018
Study Completion Date
July 1, 2018
complete remission (CR) group
According to the RECIST 1.1, 32 patients were allocated into the complete remission (CR) group based on their responses to neoadjuvant chemotherapy (NAC).
partial remission (PR) group
According to the RECIST 1.1, 61 patients were allocated into the partial remission (PR) group based on their responses to neoadjuvant chemotherapy (NAC).
stable disease (SD) group
According to the RECIST 1.1, 12 patients were allocated into the stable disease (SD) group based on their responses to neoadjuvant chemotherapy (NAC).
progressive disease (PD) group
According to the RECIST 1.1, 5 patients were allocated into the progressive disease (PD) group based on their responses to neoadjuvant chemotherapy (NAC).
the First Affiliated Hospital of China Medical University, Shenyang
Shengjing Hospital of China Medical University, Shenyang
The Second Hospital of Jilin University, Changchun
Shengjing Hospital
OTHER